Genotype-guided targeted treatment of KRAS-mutated arteriovenous malformations

J Eur Acad Dermatol Venereol. 2022 Sep;36(9):e708-e710. doi: 10.1111/jdv.18165. Epub 2022 May 3.

Authors

R Cai^#¹, Z Wang^#¹, Y Sun^#¹, X Yang¹, M Wen¹, L Zheng¹, D Wang¹, L Yu^#², X Fan^#¹, L Su^#¹

Affiliations

¹ Department of Interventional Therapy, Multidisciplinary Team of Vascular Anomalies, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, Shanghai, China.
² Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, National Children's Regional Medical Center, Hangzhou, China.

^# Contributed equally.

PMID: 35445448
DOI: 10.1111/jdv.18165

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Arteriovenous Malformations* / drug therapy
Arteriovenous Malformations* / genetics
Genotype
Humans
Mutation
Proto-Oncogene Proteins p21(ras)* / genetics

Substances

KRAS protein, human
Proto-Oncogene Proteins p21(ras)

Grants and funding